Last week, Applied Biosciences announced the completion of a year-long strategic review of its business, wrapping up the process by filling positions among its senior management. But the review process apparently didn’t jump-start revenue growth for the molecular biology tools leader.

“The overall numbers aren’t going up,” said Tony White, CEO of Applera, ABI’s parent company. He said the company modified its revenue projections for FY 2005 to low single-digit growth, from its previous projection of mid-single digit growth.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Hundreds of scientists have signed a letter criticizing the open-access Plan S, ScienceInsider reports.

NPR speaks with Rep. Eddie Bernice Johnson (D-Texas) about the US House of Representatives science committee.

A start-up company aiming to match cancer patients to treatments closes after about six weeks, Stat News reports.

In PLOS this week: somatic mutation associations unearthed in thousands of cancer exomes, pathogen detection assay, and more.